Clinical trial
Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or…
NCT00059839 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00059839 |
|---|---|
| Title | Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma |
| Official title | A Phase III Trial of Treatment of Advanced-Stage Anaplastic Large Cell Lymphoma (ALCL) With Standard APO (Doxorubicin, Prednisone, Vincristine) Versus Consolidation With a Regimen Including Vinblastine |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | doxorubicin hydrochloride, mercaptopurine, methotrexate, prednisone, vinblastine sulfate, vincristine sulfate |
| Enrollment | 129 |
| Start date | Nov 1, 2003 |
| Primary completion | Dec 1, 2009 |
| Completion | Jul 1, 2014 |
| First posted | May 7, 2003 |
| Last update posted | Sep 22, 2014 |
| Countries | Australia, Canada, Puerto Rico, Switzerland, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: